AI assistant
Medicover — M&A Activity 2017
Oct 4, 2017
2943_rns_2017-10-04_48d2abfc-13d3-4518-93ea-289001f6cbb2.pdf
M&A Activity
Open in viewerOpens in your device viewer
Press Release Stockholm 4 October, 2017
ACQUISITIONS IN INDIA COMPLETED
The earlier announced acquisitions of Medicover Healthcare Private Limited "Medicover Fertility India" and the 22% shareholding of Sahrudaya Healthcare Private Limited "MaxCure", both located in India, are now completed. The transactions were cash settled for € 18.5 million.
From 1 October 2017, Medicover Fertility's results and financial position will be consolidated and the holding in Maxcure will be accounted for as an associated company.
For further information, please contact:
Paula Treutiger, Corporate Communications & Investor Relations, Director
Phone: +46-73-66 6599 Mail: [email protected]
This information is information that Medicover AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 10.30 CET on 4 October, 2017.
Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities and laboratories and the largest markets are Poland and Germany. In 2016, Medicover had revenues around €0.5 billion and 14,400 employees. For more information, go to www.medicover.com